Anal cancer screening warranted for older cervical cancer survivors
Older women with a history of cervical cancer may benefit from screening for anal cancer, research suggests.
Invasive breast cancer survivors experience small excess risk of future malignancy
Survivors of early invasive breast cancer have a slightly higher risk of developing a second primary breast cancer and other malignancies than women without a history of the disease, demonstrates research published in The BMJ.
Targeted cancer therapy link to thromboembolism quantified
Use of targeted cancer therapies is associated with a clinically relevant increase in the risk of arterial and venous thromboembolic events, indicate findings from a population-based cohort study.
Invasive breast cancer risk quantified for DCIS patients without immediate surgery
Women who do not undergo surgery within 6 months of being diagnosed with ductal carcinoma in situ have an 11% risk of developing ipsilateral breast cancer over the following 8 years, indicates research published in The BMJ.
AI analysis aids pancreatic cancer prognostication
Artificial intelligence can expedite assessment of tumour-infiltrating lymphocytes and immune phenotype identification in resected pancreatic ductal adenocarcinoma, research demonstrates.
Low-dose olanzapine approach ‘new standard of care’ for chemotherapy nausea and vomiting
Low-dose olanzapine significantly protects against nausea and vomiting compared with placebo for women with breast cancer receiving anthracycline plus cyclophosphamide chemotherapy, show phase 3 trial findings published in The Lancet Oncology.
Elinzanetant reduces vasomotor symptoms during breast cancer endocrine therapy
The neurokinin-targeted agent elinzanetant significantly improves vasomotor symptoms in women undergoing endocrine therapy for hormone receptor-positive breast cancer, research indicates.
Solid tumour CAR T-cell therapy achieves PFS gain in gastric cancer
The first randomised controlled trial of a CAR T-cell therapy in solid tumours has achieved a significant improvement in progression-free survival for patients with advanced gastric or gastro-oesophageal junction cancer compared with physician’s choice of therapy.
Mastectomy, salpingo-oophorectomy improve BRCA breast cancer patient survival
Risk-reducing surgery leads to improved overall survival for breast cancer patients carrying a BRCA1 or BRCA2 mutation, confirm two studies published in The Lancet Oncology.
Childhood cancer survivors might benefit from cochlear implants
Childhood cancer survivors with severe to profound sensorineural hearing loss following chemotherapy or radiotherapy may be candidates for cochlear implants, US researchers believe.